Previous close | 272.22 |
Open | 272.03 |
Bid | 274.09 x 100 |
Ask | 274.74 x 100 |
Day's range | 270.26 - 274.48 |
52-week range | 204.44 - 275.00 |
Volume | |
Avg. volume | 531,836 |
Market cap | 12.168B |
Beta (5Y monthly) | 0.54 |
PE ratio (TTM) | 12.99 |
EPS (TTM) | 21.12 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 300.95 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.